OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 750-759
Open Access | Times Cited: 13
Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 750-759
Open Access | Times Cited: 13
Showing 13 citing articles:
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima
Nature Reviews Endocrinology (2025)
Closed Access | Times Cited: 2
Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima
Nature Reviews Endocrinology (2025)
Closed Access | Times Cited: 2
Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients
Ting Yan, Minghui Long, Chaoyi Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Ting Yan, Minghui Long, Chaoyi Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer
Yunkai Qie, Shiwang Huang, Chong Shen, et al.
Clinical Cancer Research (2025)
Open Access
Yunkai Qie, Shiwang Huang, Chong Shen, et al.
Clinical Cancer Research (2025)
Open Access
Real-World Evaluation of Immune-Related Endocrinopathies in Metastatic NSCLC Patients Treated with ICIs in Romania
Simona Coniac, Mariana Costache-Outas, Ionuț-Lucian Antone-Iordache, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1198-1198
Open Access
Simona Coniac, Mariana Costache-Outas, Ionuț-Lucian Antone-Iordache, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1198-1198
Open Access
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Prevalence of vertebral fractures in patients with acromegaly: A multicenter cross-sectional study
Mussa Almalki, Mohammed Almohaya, Faisal Aziz, et al.
HORMONES (2025)
Open Access
Mussa Almalki, Mohammed Almohaya, Faisal Aziz, et al.
HORMONES (2025)
Open Access
Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study
Pengfei Zhao, Jia Li, Lihong Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pengfei Zhao, Jia Li, Lihong Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 3
Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 3
Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics
Ziyang Ye, Genpeng Li, Jianyong Lei
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 11, pp. 2365-2381
Open Access | Times Cited: 2
Ziyang Ye, Genpeng Li, Jianyong Lei
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 11, pp. 2365-2381
Open Access | Times Cited: 2
Pituitary Complications of Checkpoint Inhibitor Use
Natalia Chamorro-Pareja, Alexander T. Faje, Karen K. Miller
Endocrinology (2024) Vol. 165, Iss. 9
Closed Access | Times Cited: 2
Natalia Chamorro-Pareja, Alexander T. Faje, Karen K. Miller
Endocrinology (2024) Vol. 165, Iss. 9
Closed Access | Times Cited: 2
Start codon variant in LAG3 is associated with decreased LAG-3 expression and increased risk of autoimmune thyroid disease
Saedís Saevarsdóttir, Kristbjörg Bjarnadóttir, Thorsteinn Markusson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Saedís Saevarsdóttir, Kristbjörg Bjarnadóttir, Thorsteinn Markusson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Neoadjuvant immunotherapy plus chemotherapy in high altitude natives with resectable esophageal squamous cell carcinoma in Tibet
Xizhao Sui, Duoji Danzeng, Ping Ni, et al.
Asian Journal of Surgery (2024)
Open Access | Times Cited: 1
Xizhao Sui, Duoji Danzeng, Ping Ni, et al.
Asian Journal of Surgery (2024)
Open Access | Times Cited: 1
Hypophysitis associated with immune check piont inhibitors treatment: A case report and literature review.
Jie Wei, Xingxing Han, Yutong Ye, et al.
PubMed (2024) Vol. 49, Iss. 7, pp. 1082-1088
Closed Access
Jie Wei, Xingxing Han, Yutong Ye, et al.
PubMed (2024) Vol. 49, Iss. 7, pp. 1082-1088
Closed Access
